Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 10 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 10 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 15 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 15 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 20 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 20 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 5 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 5 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 25 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 25 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 30 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 30 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
norspan 40 mikrogram/time depotplastre
mundipharma a/s - buprenorphin - depotplastre - 40 mikrogram/time
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
lercanidipinhydrochlorid "omniapharm" 20 mg filmovertrukne tabletter
orifarm a/s - lercanidipinhydrochlorid - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
lercanidipinhydrochlorid "omniapharm" 10 mg filmovertrukne tabletter
orifarm a/s - lercanidipinhydrochlorid - filmovertrukne tabletter - 10 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - søvninitierings- og vedligeholdelsesforstyrrelser - psykoleptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.